159 related articles for article (PubMed ID: 2157568)
1. Induction of B cell responsiveness to growth factors by Epstein-Barr virus conversion: comparison of endogenous factors and interleukin-1.
Blazar BA; Murphy AM
Clin Exp Immunol; 1990 Apr; 80(1):62-8. PubMed ID: 2157568
[TBL] [Abstract][Full Text] [Related]
2. B-cell-derived interleukin 1 (IL-1)-like factor. I. Relationship of production of IL-1-like factor to accessory cell function of Epstein-Barr virus-transformed human B-lymphoblast lines.
Matsushima K; Kuang YD; Tosato G; Hopkins SJ; Oppenheim JJ
Cell Immunol; 1985 Sep; 94(2):406-17. PubMed ID: 2992808
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
Tosato G; Gerrard TL; Goldman NG; Pike SE
J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor.
Wakasugi H; Rimsky L; Mahe Y; Kamel AM; Fradelizi D; Tursz T; Bertoglio J
Proc Natl Acad Sci U S A; 1987 Feb; 84(3):804-8. PubMed ID: 3027706
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-transformed B lymphocytes produce low molecular mass molecules with autocrine growth factor and competence factor activity.
Garzelli C; Bazzichi A; Dayah AM; Manunta M; Incaprera M; Falcone G
FEMS Microbiol Lett; 1992 Dec; 100(1-3):449-54. PubMed ID: 1335948
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor.
Yokoi T; Miyawaki T; Yachie A; Kato K; Kasahara Y; Taniguchi N
Immunology; 1990 May; 70(1):100-5. PubMed ID: 2162322
[TBL] [Abstract][Full Text] [Related]
7. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2.
Wakasugi N; Tagaya Y; Wakasugi H; Mitsui A; Maeda M; Yodoi J; Tursz T
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8282-6. PubMed ID: 2172979
[TBL] [Abstract][Full Text] [Related]
8. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.
Ifversen P; Zhang XM; Ohlin M; Zeuthen J; Borrebaeck CA
Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232
[TBL] [Abstract][Full Text] [Related]
9. Self-stimulating growth factor production by B-cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus.
Blazar BA; Sutton LM; Strome M
Cancer Res; 1983 Oct; 43(10):4562-8. PubMed ID: 6309371
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-5 is an autocrine growth factor for Epstein-Barr virus-transformed B lymphocytes.
Baumann MA; Paul CC
Blood; 1992 Apr; 79(7):1763-7. PubMed ID: 1313713
[TBL] [Abstract][Full Text] [Related]
11. Density-dependent responsiveness to autocrine growth factors of Epstein-Barr virus transformed human B lymphocytes.
Garzelli C; Bazzichi A; Dayah AM; Manunta M; Incaprera M
Microbiologica; 1992 Jul; 15(3):303-7. PubMed ID: 1501588
[TBL] [Abstract][Full Text] [Related]
12. In vitro transformation by Epstein-Barr virus induces a switch in growth factor and anti-IgM responsiveness in a human leukemic B cell clone.
Janssen O; Gillis S; Kabelitz D
Eur J Immunol; 1990 Jan; 20(1):7-14. PubMed ID: 2155117
[TBL] [Abstract][Full Text] [Related]
13. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells.
Tosato G; Tanner J; Jones KD; Revel M; Pike SE
J Virol; 1990 Jun; 64(6):3033-41. PubMed ID: 2159561
[TBL] [Abstract][Full Text] [Related]
14. TIMP-1/MMP-9 imbalance in an EBV-immortalized B lymphocyte cellular model: evidence for TIMP-1 multifunctional properties.
Gaudin P; Trocmé C; Berthier S; Kieffer S; Boutonnat J; Lamy C; Surla A; Garin J; Morel F
Biochim Biophys Acta; 2000 Dec; 1499(1-2):19-33. PubMed ID: 11118636
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulating activity in supernatants from EBV immortalized lymphocytes.
Blazar BA; Sutton LM; Strome M
Cancer Immunol Immunother; 1986; 22(1):62-7. PubMed ID: 3011263
[TBL] [Abstract][Full Text] [Related]
16. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of IL-4 and IL-13 on CD44 expression in the Burkitt's lymphoma B cell line BL30/B95-8 and in Epstein-Barr virus (EBV) transformed human B cells: loss of IL-13 receptors on Burkitt's lymphoma B cells.
Gee K; Kozlowski M; Kryworuchko M; Diaz-Mitoma F; Kumar A
Cell Immunol; 2001 Aug; 211(2):131-42. PubMed ID: 11591117
[TBL] [Abstract][Full Text] [Related]
18. The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes.
Stuart AD; Stewart JP; Arrand JR; Mackett M
Oncogene; 1995 Nov; 11(9):1711-9. PubMed ID: 7478598
[TBL] [Abstract][Full Text] [Related]
19. B-cell-derived interleukin-1 (IL-1)-like factor. II. Sources, effects, and biochemical properties.
Matsushima K; Tosato G; Benjamin D; Oppenheim JJ
Cell Immunol; 1985 Sep; 94(2):418-26. PubMed ID: 2992809
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors.
Lau YL; Shields JG; Levinsky RJ; Callard RE
Clin Exp Immunol; 1989 Feb; 75(2):190-5. PubMed ID: 2539277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
